-
Mashup Score: 0Allied Health Professionals Meeting | SGO - 11 month(s) ago
Sep 8 – Sep 10, 2023 Phoenix, AZ Phoenix …
Source: Society of Gynecologic OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Educational sessions from the 2023 Annual Meeting on Women’s Cancer.
Source: connected.sgo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
SGO 2023 Annual Meeting content is now available. Whether you couldn't attend or want to revisit the insightful discussions, we've got you covered. Head over to SGO ConnectEd to access select presentations! https://t.co/DI0eon2DXI #SGOMtg #PatientsPurposeProgress #SGOConnectED https://t.co/UIVeasCAdo
-
-
Mashup Score: 0Allied Health Professionals Meeting | SGO - 11 month(s) ago
Sep 8 – Sep 10, 2023 Phoenix, AZ Phoenix …
Source: Society of Gynecologic OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
đź”™ #TBT to the phenomenal SGO 2022 Allied Health Professionals Meeting! Join us September 8-10, 2023, for interactive workshops, engaging presentations, countless networking opportunities, and more! Secure your spot: https://t.co/HlmP8PdiRS #tbt #SGOAllied #SGOMtg https://t.co/MICaQybuFX
-
-
Mashup Score: 0Allied Health Professionals Meeting | SGO - 12 month(s) ago
Sep 8 – Sep 10, 2023 Phoenix, AZ Phoenix …
Source: Society of Gynecologic OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The SGO 2023 Allied Health Professionals Meeting will feature additional educational opportunities, including the popular Hands-on Workshop and a new Basics Bootcamp. Learn more and sign up to join us in Phoenix, AZ, Sept. 8-10! https://t.co/v5lT5oIXVs #SGOMtg #SGOAlliedHealth https://t.co/Y0FCknz63m
-
-
Mashup Score: 0NOVA Final Analysis Confirms No Significant Overall Survival Benefit for Maintenance Niraparib in Recurrent Ovarian Cancer - The ASCO Post - 12 month(s) ago
After resolving missing survival data in the phase III ENGOT-OV16/NOVA trial, no statistically significant difference in overall survival was found for patients with platinum-sensitive recurrent ovarian cancer who received maintenance therapy with the PARP inhibitor niraparib, investigators reported at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer.1 Once…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NOVA: Final Analysis Confirms No Significant Overall Survival Benefit for Maintenance Niraparib in Recurrent Ovarian Cancer https://t.co/uKZSvuwi2K #SGO23 #SGOmtg @SGO_org #gyncsm #ovariancancer #oncology
-
-
Mashup Score: 2SGO Presentations Explore Inequitable Access to Clinical Trials and Its Impact on Survival - The ASCO Post - 12 month(s) ago
Two studies presented at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer underscore the importance of enrolling patients with gynecologic cancer on clinical trials and of assuring trial access to racial minorities. One study found a statistically significant improvement in overall survival for patients with platinum-resistant ovarian cancer enrolled on clinical…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
SGO Presentations Explore Inequitable Access to Clinical Trials and Its Impact on Survival https://t.co/gMxFLQOs39 #SGOmtg @SGO_org #gyncsm #oncology #clinicaltrials #HealthEquity
-
-
Mashup Score: 1Allied Health Professionals Meeting | SGO - 12 month(s) ago
Sep 8 – Sep 10, 2023 Phoenix, AZ Phoenix …
Source: Society of Gynecologic OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Join us for an unforgettable experience where impactful education📚, powerful networking🤝, and cutting-edge insights💡 in gynecologic oncology collide at the Allied Health Professionals Meeting, Sept. 8-10, in Phoenix, AZ! #SGOMtg #SGOAlliedHealth https://t.co/iFqVKVuO7H
-
-
Mashup Score: 0Poor Tolerability Appears to Hinder Benefit of Adavosertib in Uterine Serous Carcinoma - The ASCO Post - 12 month(s) ago
The oral, small-molecule Wee1 kinase inhibitor adavosertib was clinically active but not well tolerated by more than half the patients with recurrent or persistent uterine serous carcinoma in the phase IIb ADAGIO trial. The findings were reported at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer by Joyce F. Liu, MD, MPH, Associate Chief and Director of Clinical…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Poor Tolerability Appears to Hinder Benefit of Adavosertib in Uterine Serous Carcinoma https://t.co/TqWnbldci1 #gyncsm #uterinecancer #oncology #SGO23 #SGOmtg @SGO_org
-
-
Mashup Score: 5GOG 3026 Durable Responses With Ribociclib Plus Letrozole in Low-Grade Serous Ovarian Cancer - The ASCO Post - 12 month(s) ago
In patients with recurrent low-grade serous ovarian cancer, treatment with ribociclib plus letrozole was not only active, but led to outcomes that are comparable to those achieved with current agents—with a particularly striking 19-month duration of response—according to Brian M. Slomovitz, MD, Professor of Obstetrics and Gynecology at Florida International University and Director of Gynecologic…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ASCOPost: GOG 3026: Durable Responses With Ribociclib Plus Letrozole in Low-Grade Serous Ovarian Cancer https://t.co/YTLwAiiWer #gyncsm…
-
GOG 3026: Durable Responses With Ribociclib Plus Letrozole in Low-Grade Serous Ovarian Cancer https://t.co/YTLwAiiWer #gyncsm #ovariancancer #oncology #SGO23 #SGOmtg @SGO_org
-
-
Mashup Score: 0Allied Health Professionals Meeting | SGO - 1 year(s) ago
Sep 8 – Sep 10, 2023 Phoenix, AZ Phoenix …
Source: Society of Gynecologic OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Registration is officially open for the SGO 2023 Allied Health Professionals Meeting. Sign up today to join us in Phoenix, AZ, this September! View the schedule, book your hotel and register here: https://t.co/kC8jIXrbKX #SGOMtg #SGOAlliedHealth https://t.co/ixewQXvuUx
-
Have you seen the updated SGO 2023 Allied Health Professionals Meeting schedule? We have some fantastic sessions and amazing speakers lined up. Check out the schedule and secure your spot to join us in Phoenix this Sept. 8-10! https://t.co/K54TkE3NuC #SGOAllied #SGOMtg https://t.co/Amz0422uDf